Leszek Lisowski
Berater bei 4BIO Ventures Management Ltd.
Profil
Leszek Lisowski founded LogicBio Therapeutics, Inc. in 2014, where he worked as President & Chief Executive Officer.
Dr. Lisowski also currently works at 4BIO Ventures Management Ltd., as Advisor.
Dr. Lisowski also formerly worked at The Salk Institute for Biological Studies, as Director from 2013 to 2015.
Dr. Lisowski received his doctorate degree in 2008 from Cornell University, undergraduate degree in 2001 from the University of Bridgeport, and Masters Business Admin degree in 2015 from the University of California San Diego.
Aktive Positionen von Leszek Lisowski
| Unternehmen | Position | Beginn |
|---|---|---|
4BIO Ventures Management Ltd.
 4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom. | Berater | - |
Ehemalige bekannte Positionen von Leszek Lisowski
| Unternehmen | Position | Ende |
|---|---|---|
| The Salk Institute for Biological Studies | Direktor/Vorstandsmitglied | 01.10.2015 |
| LOGICBIO THERAPEUTICS, INC. | Vorstandsvorsitzender | - |
Ausbildung von Leszek Lisowski
| Cornell University | Doctorate Degree |
| University of California San Diego | Masters Business Admin |
| University of Bridgeport | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
4BIO Ventures Management Ltd.
4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom. | Finance |
